Health care companies by operating margin
Operating income as a share of revenue for the latest fiscal year: what the business keeps of each dollar of sales before interest and tax. Banks, insurers and other companies that report no operating income are not ranked.
Royalty Pharma leads the 143 health care companies ranked by operating margin, at 65.6%, ahead of PTC Therapeutics (50.1%) and United Therapeutics (46.9%). Figures as of 18 Nov 2026, 20:24 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 143
- First
- Royalty Pharma65.6%
- Median
- 11.8%
- Combined market value
- HK$71.5T
- Countries
- 14
- Not ranked
- 27no operating margin on file
Market values as of .
All countries▾
Health Care▾
All categories▾
| # | Company | Operating margin ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | Royalty PharmaRPRX · Health Care | 65.6% | HK$311.7B | HK$542.15 | 0.62% up | 78% up | ||
| 2 | PTC TherapeuticsPTCT · Health Care | 50.1% | HK$39.4B | HK$471.46 | 0.44% down | 20% down | ||
| 3 | United TherapeuticsUTHR · Health Care | 46.9% | HK$193.7B | HK$4,549.00 | 0.73% down | 23% up | ||
| 4 | Krystal BiotechKRYS · Health Care | 41.5% | HK$73.1B | HK$2,467.61 | 5.35% up | 46% up | ||
| 5 | Novo NordiskNVO · Health Care | 41.3% | HK$1.36T | HK$309.50 | 3.07% down | 17% down | ||
| 6 | ExelixisEXEL · Health Care | 37.6% | HK$131.3B | HK$538.22 | 0.15% up | 63% up | ||
| 7 | Vertex PharmaceuticalsVRTX · Health Care | 34.8% | HK$1.07T | HK$4,221.89 | 0.74% up | 27% up | ||
| 8 | Gilead SciencesGILD · Health Care | 34.0% | HK$1.65T | HK$1,329.14 | 0.49% down | 33% up | ||
| 9 | Halozyme TherapeuticsHALO · Health Care | 33.6% | HK$85.9B | HK$753.22 | 0.04% up | 37% up | ||
| 10 | ResMedRMD · Health Care | 33.4% | HK$269.5B | HK$1,915.89 | 2.67% up | 3% down | ||
| 11 | NovartisNVS · Health Care | 32.4% | HK$2.3T | HK$1,217.74 | 2.46% down | 25% up | ||
| 12 | IDEXX LaboratoriesIDXX · Health Care | 31.6% | HK$433B | HK$5,495.37 | 1.48% up | 1% down | ||
| 13 | IncyteINCY · Health Care | 29.5% | HK$189.4B | HK$929.00 | 0.57% down | 18% up | ||
| 14 | Intuitive SurgicalISRG · Health Care | 29.3% | HK$1.15T | HK$3,321.06 | 1.67% down | 24% down | ||
| 15 | GenmabGMAB · Health Care | 28.6% | HK$247.4B | HK$401.29 | 1.56% down | 70% up | ||
| 16 | SolventumSOLV · Health Care | 26.2% | HK$115.5B | HK$679.60 | 0.66% up | 11% up | ||
| 17 | argenxARGX · Health Care | 25.4% | HK$466.2B | HK$7,412.91 | 0.28% down | 4% up | ||
| 18 | WatersWAT · Health Care | 25.4% | HK$715B | HK$3,637.85 | 3.09% up | 20% up | ||
| 19 | Regeneron PharmaceuticalsREGN · Health Care | 24.9% | HK$768.3B | HK$7,426.87 | 1.16% down | 36% up | ||
| 20 | AmgenAMGN · Health Care | 24.7% | HK$1.89T | HK$3,489.81 | 2.86% down | 34% up | ||
| 21 | AbbVieABBV · Health Care | 24.6% | HK$3.97T | HK$2,248.53 | 2.12% down | 26% up | ||
| 22 | HealthEquityHQY · Health Care | 24.6% | HK$63.6B | HK$768.60 | 3.80% down | 2% down | ||
| 23 | GSKGSK · Health Care | 24.3% | HK$766.3B | HK$382.30 | 1.04% down | 6% up | ||
| 24 | AstraZenecaAZN · Health Care | 23.4% | HK$2.18T | HK$1,405.20 | 1.73% down | 2% up | ||
| 25 | QiagenQGEN · Health Care | 22.3% | HK$80.4B | HK$389.28 | 0.26% down | 12% up | ||
| 26 | Neurocrine BiosciencesNBIX · Health Care | 21.6% | HK$129.1B | HK$1,275.72 | 1.99% down | 20% up | ||
| 27 | Agilent TechnologiesA · Health Care | 21.3% | HK$389.3B | HK$1,380.61 | 2.18% up | 19% up | ||
| 28 | Medpace HoldingsMEDP · Health Care | 21.1% | HK$142B | HK$5,076.00 | 0.93% down | 10% up | ||
| 29 | Edwards LifesciencesEW · Health Care | 20.8% | HK$474.8B | HK$825.67 | 0.18% down | 23% up | ||
| 30 | Bio-TechneTECH · Health Care | 20.7% | HK$89.7B | HK$571.10 | 0.23% up | 26% up | ||
| 31 | Lantheus HoldingsLNTH · Health Care | 20.2% | HK$52.3B | HK$799.98 | 0.17% up | 93% up | ||
| 32 | TG TherapeuticsTGTX · Health Care | 20.0% | HK$78.3B | HK$517.79 | 5.25% up | 107% up | ||
| 33 | MSA SafetyMSA · Health Care | 19.8% | HK$54B | HK$1,403.01 | 3.47% up | 11% up | ||
| 34 | DexComDXCM · Health Care | 19.6% | HK$241.2B | HK$646.61 | 0.46% up | 37% up | ||
| 35 | StrykerSYK · Health Care | 19.5% | HK$947.7B | HK$2,489.54 | 0.07% down | 13% down | ||
| 36 | DanaherDHR · Health Care | 19.1% | HK$1.26T | HK$1,789.82 | 1.05% up | 2% up | ||
| 37 | West Pharmaceutical ServicesWST · Health Care | 19.0% | HK$222.7B | HK$3,197.57 | 1.58% down | 61% up | ||
| 38 | IlluminaILMN · Health Care | 18.6% | HK$248B | HK$1,640.29 | 3.19% up | 69% up | ||
| 39 | STERISSTE · Health Care | 18.6% | HK$197.7B | HK$2,035.57 | 0.80% up | 1% up | ||
| 40 | Abbott LaboratoriesABT · Health Care | 18.2% | HK$1.43T | HK$823.67 | 0.27% up | 17% down | ||
| 41 | Boston ScientificBSX · Health Care | 18.0% | HK$497.6B | HK$343.27 | 1.68% up | 56% down | ||
| 42 | MedtronicMDT · Health Care | 17.8% | HK$1.01T | HK$792.71 | 1.25% down | 2% up | ||
| 43 | InsuletPODD · Health Care | 17.5% | HK$76.4B | HK$1,101.32 | 3.41% down | 58% down | ||
| 44 | Thermo Fisher ScientificTMO · Health Care | 17.4% | HK$2.01T | HK$5,423.11 | 0.65% up | 20% up | ||
| 45 | AlkermesALKS · Health Care | 17.2% | HK$61.4B | HK$365.20 | 2.42% up | 58% up | ||
| 46 | Cooper CompaniesCOO · Health Care | 16.7% | HK$91B | HK$478.64 | 0.48% up | 16% down | ||
| 47 | GrifolsGRFS · Health Care | 16.5% | HK$45.1B | HK$66.29 | 2.09% down | 1% up | ||
| 48 | Tenet HealthcareTHC · Health Care | 16.5% | HK$169.7B | HK$2,132.11 | 3.65% down | 45% up | ||
| 49 | Globus MedicalGMED · Health Care | 16.3% | HK$73.9B | HK$557.84 | 1.59% up | 16% down | ||
| 50 | Concentra Group Holdings ParentCON · Health Care | 15.4% | HK$41.4B | HK$329.30 | 0.96% down | 120% up | ||
| 51 | Ligand PharmaceuticalsLGND · Health Care | 15.3% | HK$46.8B | HK$2,341.50 | 1.58% up | 43% up | ||
| 52 | Dr. Reddy's LaboratoriesRDY · Health Care | 15.0% | HK$98.2B | HK$117.76 | 1.49% up | 5% up | ||
| 53 | DaVitaDVA · Health Care | 15.0% | HK$80.5B | HK$1,280.03 | 5.69% down | 50% up | ||
| 54 | SanofiSNY · Health Care | 14.5% | HK$888.9B | HK$370.18 | 0.73% down | 4% down | ||
| 55 | LivaNovaLIVN · Health Care | 14.4% | HK$40.7B | HK$739.02 | 2.48% up | 71% up | ||
| 56 | Quest DiagnosticsDGX · Health Care | 14.1% | HK$223.4B | HK$2,030.27 | 0.95% up | 38% up | ||
| 57 | Align TechnologyALGN · Health Care | 13.5% | HK$90.6B | HK$1,285.29 | 0.23% up | 22% up | ||
| 58 | Alnylam PharmaceuticalsALNY · Health Care | 13.5% | HK$157.1B | HK$1,172.75 | 4.48% down | 66% down | ||
| 59 | PenumbraPEN · Health Care | 13.5% | HK$99.1B | HK$2,514.99 | 0.46% up | 13% up | ||
| 60 | GE HealthCare TechnologiesGEHC · Health Care | 13.4% | HK$296.5B | HK$655.79 | 2.14% up | 13% up | ||
| 61 | IQVIA HoldingsIQV · Health Care | 13.4% | HK$334B | HK$2,026.90 | 0.30% up | 18% up | ||
| 62 | ChemedCHE · Health Care | 13.4% | HK$55.3B | HK$4,265.08 | 0.57% down | 27% up | ||
| 63 | Zimmer Biomet HoldingsZBH · Health Care | 13.3% | HK$153.4B | HK$810.81 | 1.23% up | 14% up | ||
| 64 | AlconALC · Health Care | 13.1% | HK$284B | HK$591.14 | 1.67% up | 2% down | ||
| 65 | Amneal PharmaceuticalsAMRX · Health Care | 13.1% | HK$59.6B | HK$170.99 | 3.20% up | 83% up | ||
| 66 | Smith & NephewSNN · Health Care | 12.9% | HK$99.6B | HK$238.15 | 0.50% down | 5% down | ||
| 67 | BioMarin PharmaceuticalBMRN · Health Care | 12.7% | HK$93.2B | HK$481.31 | 4.85% up | 11% up | ||
| 68 | Teva Pharmaceutical IndustriesTEVA · Health Care | 12.5% | HK$386B | HK$330.80 | 1.07% down | 74% up | ||
| 69 | RevvityRVTY · Health Care | 12.5% | HK$133.2B | HK$1,193.50 | 2.94% up | 60% up | ||
| 70 | Merit Medical SystemsMMSI · Health Care | 12.2% | HK$40.2B | HK$671.48 | 1.30% up | 1% up | ||
| 71 | Arrowhead PharmaceuticalsARWR · Health Care | 11.9% | HK$48.1B | HK$340.17 | 0.86% up | 10% up | ||
| 72 | Becton, DickinsonBDX · Health Care | 11.8% | HK$462.2B | HK$1,697.01 | 0.41% up | 43% up | ||
| 73 | HaemoneticsHAE · Health Care | 11.7% | HK$43.8B | HK$961.36 | 1.34% up | 61% up | ||
| 74 | Universal Health ServicesUHS · Health Care | 11.5% | HK$85B | HK$1,474.71 | 2.09% down | 16% down | ||
| 75 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | 11.4% | HK$58.6B | HK$745.30 | 0.12% down | 126% up | ||
| 76 | Labcorp HoldingsLH · Health Care | 9.92% | HK$235.9B | HK$2,905.65 | 0.58% up | 41% up | ||
| 77 | Fresenius Medical CareFMS · Health Care | 9.31% | HK$85.4B | HK$164.55 | 3.30% down | 5% down | ||
| 78 | Ensign GroupENSG · Health Care | 8.41% | HK$83.5B | HK$1,432.00 | 1.88% down | 4% up | ||
| 79 | BeOne MedicinesONC · Health Care | 8.37% | HK$361.7B | HK$3,166.90 | 2.32% down | 17% up | ||
| 80 | Koninklijke PhilipsPHG · Health Care | 7.98% | HK$229.2B | HK$234.42 | 0.03% down | 10% up | ||
| 81 | MedlineMDLN · Health Care | 7.78% | HK$403.7B | HK$306.75 | 3.77% up | 8% down | ||
| 82 | RepligenRGEN · Health Care | 7.47% | HK$86.4B | HK$1,351.50 | 6.22% up | 5% up | ||
| 83 | Option Care HealthOPCH · Health Care | 5.98% | HK$37.2B | HK$248.62 | 0.19% up | 14% up | ||
| 84 | TeleflexTFX · Health Care | 5.94% | HK$51.5B | HK$1,297.76 | 3.68% up | 51% up | ||
| 85 | Corcept TherapeuticsCORT · Health Care | 5.88% | HK$58.4B | HK$533.71 | 2.91% down | 8% down | ||
| 86 | PACS GroupPACS · Health Care | 5.85% | HK$57.5B | HK$362.18 | 4.91% down | 188% up | ||
| 87 | Caris Life SciencesCAI · Health Care | 5.56% | HK$44.3B | HK$154.63 | 1.15% down | 17% down | ||
| 88 | ICONICLR · Health Care | 5.37% | HK$114.5B | HK$1,528.73 | 0.08% down | 23% up | ||
| 89 | BillionToOneBLLN · Health Care | 5.25% | HK$34.1B | HK$712.78 | 6.82% down | 0% up | ||
| 90 | Henry ScheinHSIC · Health Care | 4.95% | HK$74.5B | HK$673.75 | 3.54% up | 17% up | ||
| 91 | Hims & Hers HealthHIMS · Health Care | 4.50% | HK$31.5B | HK$134.35 | 2.42% down | 51% down | ||
| 92 | UnitedHealth GroupUNH · Health Care | 4.24% | HK$2.46T | HK$2,744.98 | 10.21% down | 26% up | ||
| 93 | Elevance HealthELV · Health Care | 3.62% | HK$685B | HK$3,170.47 | 6.87% down | 37% up | ||
| 94 | Cigna GroupCI · Health Care | 3.35% | HK$587.3B | HK$2,229.00 | 3.38% down | 8% up | ||
| 95 | RadNetRDNT · Health Care | 3.04% | HK$44.8B | HK$568.70 | 3.24% down | 7% down | ||
| 96 | BrightSpring Health ServicesBTSG · Health Care | 2.29% | HK$107.2B | HK$538.97 | 1.62% down | 116% up | ||
| 97 | Bausch + LombBLCO · Health Care | 2.22% | HK$59B | HK$164.91 | 0.91% up | 42% up | ||
| 98 | HumanaHUM · Health Care | 2.09% | HK$369.4B | HK$3,075.85 | 11.57% down | 94% up | ||
| 99 | BrukerBRKR · Health Care | 1.98% | HK$75.8B | HK$496.53 | 3.15% up | 41% up | ||
| 100 | Bio-Rad LaboratoriesBIO · Health Care | 1.83% | HK$78B | HK$2,899.61 | 3.19% up | 18% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Operating margin is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Banks and insurers report no operating income and are not ranked on it. Sums are converted from US dollars at today's exchange rate (1 USD = 7.8453 HKD). 27 companies have no operating margin on file and are not ranked here.
Questions and answers
Which health care companies rank first by operating margin?
Royalty Pharma (65.6%), PTC Therapeutics (50.1%) and United Therapeutics (46.9%) are the top three of the 143 health care companies ranked by operating margin as of 18 Nov 2026, 20:24 UTC.
How many health care companies are in this ranking?
143 are ranked by operating margin. 27 more have no operating margin on file and are left out rather than ranked at zero.
What are these health care companies worth together?
The 143 health care companies ranked by operating margin have a combined market value of HK$71.5T as of 18 Nov 2026, 20:24 UTC.
What does ranking by operating margin measure?
Operating income as a share of revenue for the latest fiscal year: what the business keeps of each dollar of sales before interest and tax. Banks, insurers and other companies that report no operating income are not ranked.
Learn how this ranking works
All markets guides →- Revenue vs earnings vs free cash flow: what each tells you
Revenue is everything a company sold in a period. Earnings, or net income, is what remains after every cost, interest and tax. Free cash flow is the cash operations brought in minus spending on long-lived assets. Revenue shows size and demand, earnings show profitability, and free cash flow shows how much cash the business can actually hand out.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
- How companies are sorted into sectors and industries
Companies are sorted into sectors and industries by classification systems. The index providers MSCI and S&P Dow Jones Indices use GICS: 11 sectors split into 25 industry groups, 74 industries and 163 sub-industries. SEC filings carry a four-digit SIC code. The two can place one company differently, because each looks at the business from its own angle.
Cite this page
Funkfolio, “Health care companies by operating margin”, data as of 18 November 2026. https://funkfolio.com/companies/sector/health-care?by=operating-margin
Underlying data: Yahoo Finance; SEC EDGAR.